Bioactive Materials Derived from Menstrual Blood Stem Cells Enhance the Quality  of In Vitro Bovine Embryos

Mohammad Sobhan  Amini; Mohammad Mehdi  Naderi; Abolfazl  Shirazi; Mehdi  Aminafshar; Sara  Borjian Boroujeni; Mostafa  Pournourali; Ali  Malekpour

doi:10.18502/ajmb.v14i4.10483

Mohammad Sobhan Amini Department of Animal Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
Mohammad Mehdi Naderi Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Abolfazl Shirazi Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Mehdi Aminafshar Department of Animal Science, Science and Research Branch, Islamic Azad University, Tehran, Iran
Sara Borjian Boroujeni Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Mostafa Pournourali Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Ali Malekpour Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

DOI: https://doi.org/10.18502/ajmb.v14i4.10483

Keywords: Bovine, Embryo, In vitro production, IVM, Menstrual blood stem cells

Abstract

Backgrounds: The aim of this study was to determine whether the addition of bioactive materials derived from Menstrual Blood Stem Cells (MenSCs) to the oocyte maturation medium may improve the quality of bovine embryos in vitro.

Methods: MenSCs were collected from 6 healthy women (between 26 and 36 years old) and after 3 days of culture, their bioactive materials were frozen. The bovine Cumulus-Oocyte-Complexes (COCs) were aspirated from ovarian slaughterhouse and the oocytes with more than three layers of cumulus cells were cultured in vitro in media supplemented with (treatment) and without (control) 10% MenSCs’ bioactive materials. After IVM/IVF, the presumptive zygotes were cultured for 8 days.

Results: The blastocyst rate on day 8 in treatment group was higher than control (40.2±1.9 vs. 23±4.2.3, p=0.001). The ratio of Trophectoderm (TE) and Inner Cell Mass (ICM) (ICM/TE) cells was also greater in treatment group compared to control (30.3±2 vs. 14.9±1; p=0.001). The re-expansion of vitrified blastocysts, 24 hours after warming, in treatment group was higher than control (93.3±2.5 vs. 66.2±8.8; p=0.01). The expression of some genes related to pluripotency and implantation (OCT4, CDX2, and IFNT) were increased in treatment group compared to control (p<0/05).

Conclusion: In conclusion, the addition of MenSCs’ bioactive materials during in vitro maturation of bovine oocytes could improve the quantity and quality of bovine IVP embryos. Also, the expression of some genes associated with pluripotency and implantation in the blastocyst would be increased.